Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Conferences

ecancer travels so that you don't have to. Explore the latest conference coverage in global oncology and find out where we are going next.

AACR 2014

5 - 9 Apr 2014

TBA, San Diego, CA, United States of America

The 105th Annual Meeting of the American Association for Cancer Research will be held April 5-9, 2014, in San Diego, California. As always, this AACR Annual Meeting will highlight the latest and most exciting discoveries in every area of cancer research, and it will provide a unique opportunity for investigators from all over the world to meet, network, and forge new scientific interactions.

This year’s Annual Meeting theme, “Harnessing Breakthroughs • Targeting Cures,” reflects the great progress being made in cancer research as discoveries in the lab are translated into treatments in an increasingly targeted and precise manner. We will also continue to hold several sessions that will feature presentations of new data on cutting-edge clinical trials along with commentaries on the science behind the trials and the implications of these trials for improved patient care.

An important new feature of the AACR Annual Meeting 2014 will be to include talks by rising stars in cancer research in several of the major sessions. AACR Associate Members and early-career Active Members at the junior faculty level may apply to give a talk by submitting an extended abstract and other materials by Friday, October 18 (additional information will be available in early September). Along with the hundreds of invited talks, we will feature over 6,000 proffered papers by researchers from all over the world. We want to thank the Program Committee Co-Chairpersons for their incredible expertise, dedication, and guidance in shaping an innovative program that will be both enjoyable and educational.

It is clear that recent progress against cancer will lead to even greater opportunities for the prevention, treatment, and cures for all types of cancer as we become more entrenched in the era of precision medicine. We are confident that attending the AACR Annual Meeting will give you renewed energy, inspiration, and focus in your work. Please register early and submit your abstract by the December 3, 2013, deadline. We look forward to seeing you in San Diego.

Global prostate cancer disparities and the parts both genetic and behavioural factors play

Dr Folakemi Odedina - College of Pharmacy, University of Florida, Gainesville, USA

Global prostate cancer disparities and the parts both genetic and behavioural factors play ( Dr Folakemi Odedina - College of Pharmacy, University of Florida, Gainesville, USA )

Vitamin D as a prevention against breast cancer

Dr Song Yao - Roswell Cancer Center Institute, New York, USA

Vitamin D as a prevention against breast cancer ( Dr Song Yao - Roswell Cancer Center Institute, New York, USA )

Impact of culture, sociology and psychology on cancer and the role of AORTIC

Dr Jimmie Holland - Memorial Sloan Kettering Cancer Center, New York, U.S.A.

Impact of culture, sociology and psychology on cancer and the role of AORTIC ( Dr Jimmie Holland - Memorial Sloan Kettering Cancer Center, New York, U.S.A. )

Personalisation of leukaemia treatment using genome sequencing

Dr Giovanni Martinelli - University of Bologna, Bologna, Italy

Personalisation of leukaemia treatment using genome sequencing ( Dr Giovanni Martinelli - University of Bologna, Bologna, Italy )

New drug OTX15 shows early promise in fighting acute myeloid leukaemia

Dr Esteban Cvitkovic - Oncoethix, Lausanne, Switzerland

New drug OTX15 shows early promise in fighting acute myeloid leukaemia ( Dr Esteban Cvitkovic - Oncoethix, Lausanne, Switzerland )

High levels of mutated p53 indicate metastatic phenotype

Dr Guillermina Lozano - The University of Texas MD Anderson Cancer Center, Houston, USA

High levels of mutated p53 indicate metastatic phenotype ( Dr Guillermina Lozano - The University of Texas MD Anderson Cancer Center, Houston, USA )

History and ongoing work of AORTIC

Dr James Holland - Mount Sinai Hospital, New York, USA

History and ongoing work of AORTIC ( Dr James Holland - Mount Sinai Hospital, New York, USA )

AORTIC and the benefits of coordination between different US NCI-designated cancer centres in Kenya

Dr Lisa Stevens - National Cancer Institute, Bethesda, USA

AORTIC and the benefits of coordination between different US NCI-designated cancer centres in Kenya ( Dr Lisa Stevens - National Cancer Institute, Bethesda, USA )

Microenvironment of tumours key to cancer's progression

Dr Rakesh Jain - Harvard Medical School, Boston, USA

Microenvironment of tumours key to cancer's progression ( Dr Rakesh Jain - Harvard Medical School, Boston, USA )

Subset of breast cancer patients found to benefit from neratinib in latest trial

Dr John W. Park - University of California San Francisco, San Francisco, USA

Subset of breast cancer patients found to benefit from neratinib in latest trial ( Dr John W. Park - University of California San Francisco, San Francisco, USA )

New antibody-drug conjugate shows early promise against all forms of melanoma

Dr Jeffrey Infante - Tennessee Oncology, Nashville, USA

New antibody-drug conjugate shows early promise against all forms of melanoma ( Dr Jeffrey Infante - Tennessee Oncology, Nashville, USA )

Phase II trial shows dacomitinib benefits a subgroup of patients with head and neck cancer

Dr Byoung Chul Cho - Yonsei University College of Medicine, Seoul, Republic of Korea

Phase II trial shows dacomitinib benefits a subgroup of patients with head and neck cancer ( Dr Byoung Chul Cho - Yonsei University College of Medicine, Seoul, Republic of Korea )

Phase I trial shows the benefits of OTX015 in treating blood cancer

Dr Esteban Cvitkovic - Oncoethix, Lausanne, Switzerland

Phase I trial shows the benefits of OTX015 in treating blood cancer ( Dr Esteban Cvitkovic - Oncoethix, Lausanne, Switzerland )

"Exciting" implications of bemacyclib study in the treatment of breast cancer

Dr Amita Patnaik - South Texas Accelerated Research Therapeutics, San Antonio, USA

"Exciting" implications of bemacyclib study in the treatment of breast cancer ( Dr Amita Patnaik - South Texas Accelerated Research Therapeutics, San Antonio, USA )

Immunotherapy in melanoma

Dr Adil I. Daud - University of California San Francisco School of Medicine, San Francisco, USA

Immunotherapy in melanoma ( Dr Adil I. Daud - University of California San Francisco School of Medicine, San Francisco, USA )

Role of AORTIC in dealing with rising cancer rates in Africa

North American Vice president of AORTIC

Role of AORTIC in dealing with rising cancer rates in Africa ( North American Vice president of AORTIC )

AG-221 shows clinical activity in acute myeloid leukaemia

Dr Eytan Stein - Memorial Sloan Kettering Cancer Center, New York, USA

AG-221 shows clinical activity in acute myeloid leukaemia ( Dr Eytan Stein - Memorial Sloan Kettering Cancer Center, New York, USA )

Impact of the liver environment upon the efficacy of induction therapy

Dr Frederic Bibeau - Institut regional du Cancer, Montpellier, France

Impact of the liver environment upon the efficacy of induction therapy ( Dr Frederic Bibeau - Institut regional du Cancer, Montpellier, France )

Study identifies new strategy to overcome breast cancer resistance to HER2-targeted therapies

Dr Joan Garrett - Vanderbilt University Medical Center, Nashville, USA

Study identifies new strategy to overcome breast cancer resistance to HER2-targeted therapies ( Dr Joan Garrett - Vanderbilt University Medical Center, Nashville, USA )

Promising advances in the treatment of lung cancer using MK-3475 as an immune checkpoint inhibitor

Dr Leena Gandhi - Dana-Farber Cancer Institute, Harvard Medical School, Boston, USA

Promising advances in the treatment of lung cancer using MK-3475 as an immune checkpoint inhibitor ( Dr Leena Gandhi - Dana-Farber Cancer Institute, Harvard Medical School, Boston, USA )

Effective use of ibrutinib in the treatment of ABC lymphoma tumours

Dr Louis Staudt - National Cancer Institute, Bethesda, USA

Effective use of ibrutinib in the treatment of ABC lymphoma tumours ( Dr Louis Staudt - National Cancer Institute, Bethesda, USA )

New drug demonstrates early promise in metastatic breast cancer

Dr Amita Patnaik - South Texas Accelerated Research Therapeutics, San Antonio, USA

New drug demonstrates early promise in metastatic breast cancer ( Dr Amita Patnaik - South Texas Accelerated Research Therapeutics, San Antonio, USA )

Biomarker identifies melanoma patients who may respond to immunotherapy MK-3475

Dr Adil I. Daud - University of California San Francisco School of Medicine, San Francisco, USA

Biomarker identifies melanoma patients who may respond to immunotherapy MK-3475 ( Dr Adil I. Daud - University of California San Francisco School of Medicine, San Francisco, USA )

Study shows benefits in use of AG-221 in advanced blood cancers

Dr Eytan Stein - Memorial Sloan Kettering Cancer Center, New York, USA

Study shows benefits in use of AG-221 in advanced blood cancers ( Dr Eytan Stein - Memorial Sloan Kettering Cancer Center, New York, USA )

Benefits found for lung cancer patients with high levels of PD-L1 with MK-3475 treatment

Dr Leena Gandhi - Dana-Farber Cancer Institute, Harvard Medical School, Boston, USA

Benefits found for lung cancer patients with high levels of PD-L1 with MK-3475 treatment ( Dr Leena Gandhi - Dana-Farber Cancer Institute, Harvard Medical School, Boston, USA )

Promising research on the use of palbociclib in the treatment of breast cancer

Dr Richard Finn - Ronald Reagan UCLA Medical Center, Los Angeles, USA

Promising research on the use of palbociclib in the treatment of breast cancer ( Dr Richard Finn - Ronald Reagan UCLA Medical Center, Los Angeles, USA )

Role of genomics in assessing risk, especially in ovarian cancer

Dr Thomas Sellers - Moffitt Cancer Center, Tampa, USA

Role of genomics in assessing risk, especially in ovarian cancer ( Dr Thomas Sellers - Moffitt Cancer Center, Tampa, USA )

Coffee as a preventative measure against liver cancer

Dr Veronica Wendy Setiawan - University of Southern California, Los Angeles, USA

Coffee as a preventative measure against liver cancer ( Dr Veronica Wendy Setiawan - University of Southern California, Los Angeles, USA )

The relationship between obesity and cancer, and other dietary factors

Dr Walter C. Willett - Harvard School of Public Health, Boston, USA

The relationship between obesity and cancer, and other dietary factors ( Dr Walter C. Willett - Harvard School of Public Health, Boston, USA )

New antibody-drug conjugate shows early promise against all forms of melanoma

Dr Jeffrey Infante - Tennessee Oncology, Nashville, USA

New antibody-drug conjugate shows early promise against all forms of melanoma ( Dr Jeffrey Infante - Tennessee Oncology, Nashville, USA )

I-SPY 2 trial shows promising development for some breast cancer patients using neratinib

Dr John W. Park - University of California, San Francisco Hellen Diller Family Comprehensive Cancer Center, San Francisco, USA

I-SPY 2 trial shows promising development for some breast cancer patients using neratinib ( Dr John W. Park - University of California, San Francisco Hellen Diller Family Comprehensive Cancer Center, San Francisco, USA )

More from ecancer